Literature DB >> 20066570

Outcome after curative resection of large (>or=10 cm) gastric gastrointestinal stromal tumors: how frequent is adjacent organ involvement and is concomitant distal pancreatectomy necessary?

Brian K P Goh1, Pierce K H Chow, Sittampalam M Kesavan, Wai-Ming Yap, Yaw-Fui A Chung, Wai-Keong Wong.   

Abstract

INTRODUCTION: Complete tumor resection with clear margins including adjacent organs is the treatment of choice for gastrointestinal stromal tumors (GISTs). However, true tumor invasion of adjacent organs has been reported to be rare. Concomitant distal pancreatectomy (DP) for suspected tumor infiltration is not infrequently performed during resection of large gastric GISTs. This study aims to determine the true frequency of adjacent organ involvement by large gastric GISTs with particular attention to the pancreas and compares the outcome after curative resection with and without a concomitant DP in order to determine if DP is truly necessary.
METHODS: A retrospective review of 37 patients who underwent curative resection of large (>or=10 cm) gastric GISTs was conducted.
RESULTS: Wedge resections were performed in 22, partial gastectomies in nine, and total gastrectomies in six patients. The median operative time was 180 min (range, 60-330 min), and the patients had a median postoperative stay of 8 days (range, 4-29 days). Overall, there were eight (22%) morbidities including two (5%) mortalities. Nineteen (51%) had concomitant adjacent organ resection, and these included 15 (41%) DPs with splenectomies. Direct organ invasion was demonstrated in 5/19 patients (26%) and 7/30 organs (23%) resected. Only 1/15 (6.7%) DP specimens demonstrated tumor infiltration. Comparison between the patients with and without a concomitant DP demonstrated that performance of a DP was associated with a longer operation time [225 min (range, 105-305 min) vs 158 min (60-330 min), P=.002)], increased postoperative stay [9 days (range, 7-29 days) vs 7.5 days (4-19 days), P=.042], and increased postoperative morbidity [6 (40%) vs 2 (9%), P=.025]. The DP cohort also had a statistically significant poorer 5-year recurrence free survival (22% vs 60%, P=.017).
CONCLUSION: Although adjacent organ involvement is not uncommon with large gastric GISTs, concomitant DP is usually unnecessary as direct pancreatic invasion is rare. Furthermore, concomitant DP with splenectomy is associated with an increase in postoperative morbidity.

Entities:  

Mesh:

Year:  2010        PMID: 20066570     DOI: 10.1007/s11605-009-1083-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate.

Authors:  B K P Goh; P K H Chow; K L Chuah; W M Yap; W K Wong
Journal:  Eur J Surg Oncol       Date:  2006-07-12       Impact factor: 4.424

3.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

4.  Presentation and management of gastrointestinal stromal tumors of the duodenum.

Authors:  Robert D Winfield; Steven N Hochwald; Stephen B Vogel; Alan W Hemming; Chen Liu; William G Cance; Stephen R Grobmyer
Journal:  Am Surg       Date:  2006-08       Impact factor: 0.688

Review 5.  Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management.

Authors:  I Pidhorecky; R T Cheney; W G Kraybill; J F Gibbs
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

Review 6.  Gastrointestinal stromal tumours.

Authors:  E M Connolly; E Gaffney; J V Reynolds
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

7.  Clinical management of gastrointestinal stromal tumors: before and after STI-571.

Authors:  Ronald P Dematteo; Michael C Heinrich; Wa'el M El-Rifai; George Demetri
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 8.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

9.  Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.

Authors:  Brian K P Goh; Pierce K H Chow; Wai-Ming Yap; Sittampalam M Kesavan; In-Chin Song; Pradeep G Paul; Boon-Swee Ooi; Yaw-Fui A Chung; Wai-Keong Wong
Journal:  Ann Surg Oncol       Date:  2008-06-11       Impact factor: 5.344

10.  Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases.

Authors:  Jörg Kleeff; Markus K Diener; Kaspar Z'graggen; Ulf Hinz; Markus Wagner; Jeannine Bachmann; Jörg Zehetner; Michael W Müller; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more
  5 in total

1.  Laparoscopic wedge resection for suspected large (≥5 cm) gastric gastrointestinal stromal tumors.

Authors:  Chun Yuet Khoo; Brian K P Goh; Alvin K H Eng; Weng-Hoong Chan; Melissa C C Teo; Alexander Y F Chung; Hock-Soo Ong; Wai-Keong Wong
Journal:  Surg Endosc       Date:  2016-09-08       Impact factor: 4.584

2.  Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GIST.

Authors:  Abbas Agaimy; Nikolaos Vassos; Peter H Wunsch; Werner Hohenberger; Arndt Hartmann; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

3.  Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10  cm: A Single-Institution Experience in China.

Authors:  Chaoyong Shen; Haining Chen; Yuan Yin; Jiaju Chen; Sumin Tang; Bo Zhang; Luyin Han; Zhixin Chen; Jiaping Chen
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Prognostic impact of preoperative neutrophil-lymphocyte ratio for surgically resected gastrointestinal stromal tumors.

Authors:  Jing Yang; YuanHui Gu; XianBin Huang; JiaYu Xu; Yan Zhang; XiaoJun Yang; HongWei Tian; WeiPeng Zhan
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis.

Authors:  Zhe-Wei Wei; Wei-Bin Huang; Dong-Jie Yang; Yu-Jie Yuan; Yu-Long He; Chang-Hua Zhang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.